List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 21 studies with search of: Open Studies | "Telangiectasis"
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Effect of Avastin in Juxtafoveal Telangiectasias
Condition: Telangiectasis
Interventions: Drug: Bevacizumab;   Procedure: Intravitreal injection of Bevacizumab
2 Recruiting Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness
Conditions: Telangiectasis;   Erythema
Interventions: Device: Pulsed dye laser;   Device: Intense pulsed light
3 Recruiting Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
Conditions: Ataxia Telangiectasia;   Growth Failure
Intervention: Drug: Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate
4 Recruiting Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth
Condition: Macular Telangiectasia
Intervention: Drug: Ranibizumab
5 Recruiting Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study
Condition: Hemorrhagic Hereditary Telangiectasia
Intervention: Drug: Bevacizumab
6 Recruiting Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention:
7 Recruiting Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention:
8 Recruiting Baclofen Treatment of Ataxia Telangiectasia
Condition: Ataxia Telangiectasia (A-T)
Intervention: Drug: Baclofen or Placebo
9 Recruiting Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention:
10 Recruiting Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of Age-Related Macular Degeneration (AMD) and Other Related Maculopathy
Conditions: Coats’ Disease;   Idiopathic Perifoveal Telangiectasia;   Retinal Angiomatous Proliferation;   Polypoidal Vasculopathy;   Pseudoxanthoma Elasticum;   Pathological Myopia;   Multi-Focal Choroiditis;   Rubeosis Iridis
Intervention: Drug: ranibizumab injection (0.5 mg)
11 Recruiting Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding
Conditions: Arteriovenous Malformation;   Hereditary Hemorrhagic Telangiectasia;   Hematochezia;   Melena
Intervention: Drug: Thalidomide
12 Recruiting Ranibizumab Injections to Treat Macular Telangiectasia With New Blood Vessel Growth
Condition: Neovascularization
Intervention: Drug: Ranibizumab
13 Not yet recruiting Enhanced Safety Aesthetic Laser System
Conditions: Hirsutism;   Hypertrichosis;   Telangiectases;   Rhytides
Intervention: Device: Peterio
14 Recruiting Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
Conditions: Ataxia;   Chorea;   Dystonia;   Parkinsonism;   Fatigue
Intervention: Drug: amantadine sulphate
15 Recruiting Phase 2 Study of PEG-Intron in Hereditary Hemorrhagic Telangiectasia
Conditions: Anemia;   Liver Disease;   Hypoxemia
Interventions: Drug: pegylated interferon alpha2b;   Other: Standard care
16 Recruiting ATERO : A Randomised Study With Tranexamic Acid in Epistaxis of Rendu Osler Syndrome
Conditions: Telangiectasia, Hereditary Hemorrhagic;   Osler-Rendu Disease
Intervention: Drug: tranexamic acid
17 Recruiting Studies of White Blood Cells Derived From HHT Patients
Condition: Telangiectasia, Hereditary Hemorrhagic
Intervention:
18 Not yet recruiting Open Label Pilot Study of Apremilast in Treatment of Rosacea
Conditions: Erythematotelangiectatic Rosacea;   Papulopustular Rosacea
Intervention: Drug: Apremilast
19 Recruiting Combination Therapy for the Treatment of Rosacea
Condition: Erythematotelangiectatic Rosacea
Interventions: Drug: calcium dobesilate;   Procedure: pulsed dye laser
20 Recruiting T Lymphocytes in Treating Patients Undergoing a Donor Bone Marrow Transplant
Condition: Cancer
Interventions: Biological: allogeneic Epstein-Barr virus-specific cytotoxic T lymphocytes;   Genetic: polymerase chain reaction;   Other: immunological diagnostic method;   Procedure: adjuvant therapy

Previous Page Studies Shown (1-20) Next Page (21-21)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services